首页> 外文期刊>European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V >Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
【24h】

Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.

机译:盐酸二甲双胍缓释微丸的制备及体外/体内评价。

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, metformin hydrochloride (MH) sustained-release pellets were successfully prepared by centrifugal granulation. Seed cores preparation, drug layering, talc modification and coating of polymeric suspensions were carried out in a centrifugal granulator. Talc modification was performed before coating in order to overcome the high water solubility of metformin. The influence of surface modification by talc, the effects of Eudragit types and ratios, as well as the correlation between in vitro release and in vivo absorption were investigated in detail. Experimental results indicated that talc modification made a decisive contribution to controlling the drug release by avoiding drug dumping. Three dissolution media: 0.1 M HCl, distilled water and pH 6.8 phosphate buffer were employed to determine the in vitro release behaviors of the above metformin hydrochloride pellets. The relative bioavailability of the sustained-release pellets was studied in 12 healthy volunteers after oral administration in a fast state using a commercially available immediate release tablet (Glucophage) as a reference. Following coating with a blend of Eudragit L30D-55 and Eudragit NE30D (1:20), at 7% or 10% coating level, respectively (referred to as F-2, F-3), the pellets acquired perfect sustained-release properties and good relative bioavailability. The Cmax, Tmax and relative bioavailability for F-2 and F-3 coated pellets were 1.21 microg/ml, 6 h, 97.6% and 1.65 microg/ml, 8 h, 165%, respectively. Combined use of two Eudragit polymers with different features as coating materials produced the desired results. Restricted delivery of metformin hydrochloride to the small intestine from differently coated pellets resulted in increased relative bioavailability and a sustained release effect. The adoption of several different pH dissolution media established a better relationship between the in vitro release and in vivo absorption of the sustained-release pellets.
机译:在这项研究中,成功​​地通过离心制粒制备了盐酸二甲双胍(MH)缓释微丸。种子芯的制备,药物分层,滑石改性和聚合物悬浮液的包衣均在离心制粒机中进行。为了克服二甲双胍的高水溶性,在涂覆前进行滑石粉改性。详细研究了滑石粉对表面改性的影响,Eudragit类型和比例的影响以及体外释放与体内吸收之间的相关性。实验结果表明,滑石粉修饰通过避免药物倾倒对控制药物释放起了决定性作用。三种溶出介质:0.1 M HCl,蒸馏水和pH 6.8磷酸盐缓冲液用于测定上述盐酸二甲双胍颗粒的体外释放行为。使用市售速释片(Glucophage)作为参考,在口服后以快速状态在12位健康志愿者中研究了缓释微丸的相对生物利用度。用Eudragit L30D-55和Eudragit NE30D(1:20)的混合物分别以7%或10%的包衣水平(称为F-2,F-3)包衣后,颗粒获得了理想的缓释性能和良好的相对生物利用度F-2和F-3包衣小丸的Cmax,Tmax和相对生物利用度分别为1.21 microg / ml,6 h,97.6%和1.65 microg / ml,8 h,165%。两种具有不同功能的Eudragit聚合物作为涂料的组合使用可产生所需的结果。盐酸二甲双胍从不同包衣的小丸向小肠的限制递送导致相对生物利用度的提高和持续释放的作用。几种不同的pH溶出介质的采用在缓释微丸的体外释放与体内吸收之间建立了更好的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号